Use of Narrative Voice and Introduction Content to Improve Interactive Voice Response Surveys in Bangladesh and Uganda

NCT ID: NCT03772431

Last Updated: 2023-05-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5580 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-26

Study Completion Date

2017-07-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the effect of two different narrative voices (one male and one female) and two different introductions (one with informational content and the other with additional motivational content) on interactive voice response (IVR) survey cooperation, response, refusal, and contact rates, as compared to a control group (male, informational), in Bangladesh and Uganda.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using random digit dialing (RDD) sampling techniques, participants were randomized to one of four arms: 1) male narrator and informational survey introduction, 2) male narrator and motivational survey introduction, 3) female narrator and informational survey introduction, and 4) female narrator and motivational survey introduction,male motivational, female informational, female motivational) which were then followed by a noncommunicable disease risk factor survey. This mobile phone survey was sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; if you are female, press 2). This study was conducted in both Bangladesh and Uganda.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surveys and Questionnaires Noncommunicable Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants were randomized to one of four narrator/introduction combinations: 1) male voice, informational content; 2) male voice, motivational content; 3) female voice, informational content; 4) female voice, motivational content.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Male Informational

Male voice, informational introduction

Group Type EXPERIMENTAL

Male Voice

Intervention Type OTHER

The survey was narrated by a male voice

Informational Introduction

Intervention Type OTHER

The survey introduction was worded to include informational content

Male Motivational

Male voice, motivational introduction

Group Type EXPERIMENTAL

Motivational Introduction

Intervention Type OTHER

The survey introduction was worded to include motivational content

Male Voice

Intervention Type OTHER

The survey was narrated by a male voice

Female Informational

Female voice, informational introduction

Group Type EXPERIMENTAL

Female Voice

Intervention Type OTHER

The survey was narrated by a female voice

Informational Introduction

Intervention Type OTHER

The survey introduction was worded to include informational content

Female Motivational

Female voice, motivational introduction

Group Type EXPERIMENTAL

Female Voice

Intervention Type OTHER

The survey was narrated by a female voice

Motivational Introduction

Intervention Type OTHER

The survey introduction was worded to include motivational content

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Female Voice

The survey was narrated by a female voice

Intervention Type OTHER

Motivational Introduction

The survey introduction was worded to include motivational content

Intervention Type OTHER

Male Voice

The survey was narrated by a male voice

Intervention Type OTHER

Informational Introduction

The survey introduction was worded to include informational content

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Access to a mobile phone
* Greater or equal to 18 years of age
* In Bangladesh, conversant in either English or Bangla language. In Uganda, conversant in either Luo, Luganda, Runyakitara or English languages.

Exclusion Criteria

* Less than 18 years of age
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Bloomberg Family Foundation, Inc.

OTHER

Sponsor Role collaborator

Makerere University

OTHER

Sponsor Role collaborator

Institute of Epidemiology, Disease Control and Research

OTHER

Sponsor Role collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adnan A Hyder, PhD, MBBS

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University Bloomberg School of Public Health

George W. Pariyo, PhD

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University Bloomberg School of Public Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Epidemiology Disease Control and Research

Dhaka, , Bangladesh

Site Status

Makerere University School of Public Health

Kampala, , Uganda

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bangladesh Uganda

References

Explore related publications, articles, or registry entries linked to this study.

Gibson DG, Pariyo GW, Wosu AC, Greenleaf AR, Ali J, Ahmed S, Labrique AB, Islam K, Masanja H, Rutebemberwa E, Hyder AA. Evaluation of Mechanisms to Improve Performance of Mobile Phone Surveys in Low- and Middle-Income Countries: Research Protocol. JMIR Res Protoc. 2017 May 5;6(5):e81. doi: 10.2196/resprot.7534.

Reference Type BACKGROUND
PMID: 28476729 (View on PubMed)

Gibson DG, Pereira A, Farrenkopf BA, Labrique AB, Pariyo GW, Hyder AA. Mobile Phone Surveys for Collecting Population-Level Estimates in Low- and Middle-Income Countries: A Literature Review. J Med Internet Res. 2017 May 5;19(5):e139. doi: 10.2196/jmir.7428.

Reference Type BACKGROUND
PMID: 28476725 (View on PubMed)

Gibson DG, Farrenkopf BA, Pereira A, Labrique AB, Pariyo GW. The Development of an Interactive Voice Response Survey for Noncommunicable Disease Risk Factor Estimation: Technical Assessment and Cognitive Testing. J Med Internet Res. 2017 May 5;19(5):e112. doi: 10.2196/jmir.7340.

Reference Type BACKGROUND
PMID: 28476724 (View on PubMed)

Hyder AA, Wosu AC, Gibson DG, Labrique AB, Ali J, Pariyo GW. Noncommunicable Disease Risk Factors and Mobile Phones: A Proposed Research Agenda. J Med Internet Res. 2017 May 5;19(5):e133. doi: 10.2196/jmir.7246.

Reference Type BACKGROUND
PMID: 28476722 (View on PubMed)

Labrique A, Nagarajan M, Kibria GMA, Vecino-Ortiz A, Pariyo GW, Ali J, Kaufman MR, Gibson D. Improving success of non-communicable diseases mobile phone surveys: Results of two randomized trials testing interviewer gender and message valence in Bangladesh and Uganda. PLoS One. 2023 May 24;18(5):e0285155. doi: 10.1371/journal.pone.0285155. eCollection 2023.

Reference Type DERIVED
PMID: 37224125 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00007318-3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.